HFG Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,466
Closed -$249K 120
2026
Q1
$249K Buy
3,466
+693
+25% +$53.4K 0.18% 93
2025
Q4
$220K Hold
2,773
0.16% 96
2025
Q3
$209K Buy
+2,773
New +$190K 0.15% 99
2022
Q3
Sell
-6,426
Closed -$595K 82
2022
Q2
$595K Hold
6,426
0.8% 38
2022
Q1
$650K Buy
6,426
+960
+18% +$101K 0.74% 37
2021
Q4
$564K Buy
+5,466
New +$505K 0.64% 40

Other funds holding CVS

HFG Advisors's CVS Position: Q2 2026 in Review

HFG Advisors sold out of CVS Health (CVS) in Q2 2026, closing a stake of 3,466 shares — an estimated $249K sold.

HFG Advisors first reported a position in CVS in Q4 2021 and held it in 6 quarters. The position peaked at $650K in Q1 2022. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • HFG Advisors reported no remaining CVS Health position as of Q2 2026 after selling out during the quarter.
  • HFG Advisors sold 3,466 CVS Health shares in Q2 2026, an estimated $249K.
  • HFG Advisors first reported a position in CVS Health in Q4 2021 and held it in 6 quarters.
  • HFG Advisors's CVS Health position peaked at $650K in Q1 2022.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on HFG Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.